Press Releases

Year

Nov 2023

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024

SALT LAKE CITY , Nov. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023 .

PDF Version

Nov 2023

LifeVantage® Introduces TrueScience® TrueRenew Daily Firming Complex, A Better-than-Cosmetic Retinol Alternative

Latest skincare innovation is the perfect addition to the internal activation benefits of Protandim ® Nrf2 Synergizer ® and TrueScience ® Liquid Collagen. Delivers retinol-like benefits without the harsh side effects for visibly enhanced, age-defying results. SALT LAKE CITY , Nov.

PDF Version

Oct 2023

LifeVantage President and CEO Steve Fife Sends Letter to Stockholders

Reminds Stockholders to Vote the WHITE Proxy Card to Ensure Continued Progress SALT LAKE CITY , Oct. 30, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health

PDF Version

Oct 2023

LifeVantage to Announce First Quarter Fiscal Year 2024 Results on November 9, 2023

SALT LAKE CITY , Oct. 26, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its first quarter ended September 30, 2023 , after

PDF Version

Oct 2023

LifeVantage Responds to Radoff-Sudbury Group’s False Allegations

SALT LAKE CITY , Oct. 25, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today issued the following statement in response to a press release issued

PDF Version

Oct 2023

LifeVantage Sends Letter and Stock Chart to Stockholders Highlighting Stock Outperformance in 2023

Urges Stockholders to Vote “FOR” LifeVantage’s Seven Highly Engaged Directors on the WHITE Universal Proxy Card to Ensure Continued Progress SALT LAKE CITY , Oct. 18, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness

PDF Version

Oct 2023

LifeVantage Sends Letter to Stockholders and Releases Investor Presentation Detailing Success of Ongoing Transformation

Highlights Decisive Actions Taken by Board to Rebuild Senior Leadership Team and Develop New LV360 Strategy That Is Delivering Results Urges Stockholders to Vote “FOR” LifeVantage’s Seven Highly Engaged Directors on the WHITE Universal Proxy Card SALT LAKE CITY , Oct.

PDF Version

Oct 2023

LifeVantage “All In” Global Convention 2023 Showcases Next Phases of LV360, Consultant Training, Product Reveals, New Sales Incentives, and More

Convention hosted in San Antonio, TX, October 5-7, attended by over 2,000 Independent Consultants from around the world SALT LAKE CITY , Oct. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products

PDF Version

Oct 2023

LifeVantage Directors Who Are Not Targeted by Dissident Stockholder Encourage LifeVantage Stockholders to Vote for All of the Board’s Director Candidates

Send Letter to Stockholders Detailing the Value Delivered by the Targeted Directors SALT LAKE CITY , Oct. 05, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health

PDF Version

Sep 2023

LifeVantage Files Definitive Proxy Statement

Issues Letter to Stockholders Highlighting the Company’s Transformation and Progress with LV360 Plan Board Comments on the Radoff - Sudbury Group’s Distracting and Costly Campaign to Remove and Replace Highly Qualified, Experienced Directors, Giving them Outsized and Unwarranted Representation on

PDF Version

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page